(Q46760849)

25 December 2017

title

Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment (English)

1 reference

25 December 2017

1 reference

1 reference

1 reference

Preeti Lal

1

1 reference

25 December 2017

Zheng Su

2

1 reference

25 December 2017

Cecile T J Holweg

3

1 reference

25 December 2017

Gregg J Silverman

4

1 reference

25 December 2017

Sergio Schwartzman

5

1 reference

25 December 2017

Ariella Kelman

6

1 reference

25 December 2017

Simon Read

7

1 reference

25 December 2017

Greg Spaniolo

8

1 reference

25 December 2017

John G Monroe

9

1 reference

25 December 2017

Timothy W Behrens

10

1 reference

25 December 2017

Michael J Townsend

11

1 reference

25 December 2017

publication date

1 December 2011

1 reference

25 December 2017

published in

Arthritis & Rheumatology

1 reference

25 December 2017

volume

63

1 reference

25 December 2017

issue

12

1 reference

25 December 2017

page(s)

3681-3691

1 reference

25 December 2017

The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis

cites work

1 reference

Progression in early rheumatoid arthritis

21 January 2018

1 reference

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

21 January 2018

1 reference

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

21 January 2018

1 reference

Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy

21 January 2018

1 reference

A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores

21 January 2018

1 reference

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

21 January 2018

1 reference

Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks

21 January 2018

1 reference

B cell immunobiology in disease: evolving concepts from the clinic

21 January 2018

1 reference

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab'

21 January 2018

1 reference

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

21 January 2018

1 reference

Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results

21 January 2018

1 reference

Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response

21 January 2018

1 reference

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

21 January 2018

1 reference

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

21 January 2018

1 reference

Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment

21 January 2018

1 reference

Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice.

21 January 2018

1 reference

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

21 January 2018

1 reference

Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis

21 January 2018

1 reference

Understanding the mechanistic basis in rheumatoid arthritis for clinical response to anti-CD20 therapy: the B-cell roadblock hypothesis

21 January 2018

1 reference

Proteomic analysis of secreted proteins in early rheumatoid arthritis: anti-citrulline autoreactivity is associated with up regulation of proinflammatory cytokines

21 January 2018

1 reference

Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues

21 January 2018

1 reference

Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair

21 January 2018

1 reference

Proinflammatory cytokines in CRP baseline regulation

21 January 2018

1 reference

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study

21 January 2018

1 reference

Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome.

21 January 2018

1 reference

Antibodies to citrullinated proteins in arthritis: pathology and promise

21 January 2018

1 reference

Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis

21 January 2018

1 reference

Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study

21 January 2018

1 reference

Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation

21 January 2018

1 reference

Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.30596

1 reference

25 December 2017

1 reference

25 December 2017